|
| Exchange Disseminated Time 08/05/2017 19:27:10 | Bliss GVS Pharma Ltd has informed BSE that the Board Meeting of the Company is scheduled to be held on May 16, 2017, inter alia, to consider the Audited Standalone and Consolidated Financial Results of the Company for the year ended March 31, 2017 and dividend if any.
Further, Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with the provision of the code of fair disclosure of the Company, the trading window of the Company will be closed from May 09, 2017 to May 18, 2017 (both days inclusive). |
|
|